DOCPLANET COM INC
NT 10-K, 2000-11-30
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: PRINTRONIX INC, S-8, EX-23.1, 2000-11-30
Next: CHURCH & DWIGHT CO INC /DE/, 4/A, 2000-11-30



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                                      SEC File Number: 000-09065
                     FORM 12b-25     CUSIP Number: _________


                           NOTIFICATION OF LATE FILING

(Check  One):  (X) Form 10-KSB  ( ) Form 20-F  ( ) Form 11-K ( ) Form 10-QSB
               ( ) Form N-SAR

     For  Period  Ended: August 31, 2000

     ( )     Transition  Report  on  Form  10-K
     ( )     Transition  Report  on  Form  20-F
     ( )     Transition  Report  on  Form  11-K
     ( )     Transition  Report  on  Form  10-Q
     ( )     Transition  Report  on  Form  N-SAR

     For  the  Transition  Period  Ended:

             ------------------------------------------------------

  Read Instructions (on back page) Before Preparing Form, Please Print or Type.
    Nothing in this form shall be construed to imply that the Commission has
                  verified any information contained herein.

             ------------------------------------------------------

If  the  notification relates to a portion of the filing checked above, identify
the  Item(s)  to  which  the  notification  relates:



                         PART I - REGISTRANT INFORMATION


DOCPLANET.COM, INC.
----------------------------------
Full  Name  of  Registrant

----------------------------------
Former  Name  if  Applicable


<PAGE>
3000 W. Warner Ave
----------------------------------
Address of Principal Executive Office (Street and Number)

Santa Ana, CA 92704-5311
----------------------------------
City,  State  and  Zip  Code


                        PART II - RULES 12b-25(b) and (c)

If  the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be  completed.  (Check  box  if  appropriate)

     (X)     (a)     The  reasons  described in reasonable detail in Part III of
this  form  could  not  be  eliminated  without  unreasonable effort or expense;

     (X)     (b)     The  subject  annual report, semi-annual report, transition
report  on  Form 10-KSB, Form 20-F, 11K, Form N-SAR, or portion thereof, will be
filed on or before the fifteenth calendar day following the prescribed due date;
or  the  subject  quarterly  report  of transition report on the Form 10-QSB, or
portion thereof will be filed on or before the fifth  calendar day following the
prescribed  due  date;  and

     ( )     (c)     The  accountant's  statement  or  other exhibit required by
Rule  12b-25(c)  has  been  attached  is  applicable.


<PAGE>
                              PART III - NARRATIVE

     State  below  in  reasonable  detail the reasons why the Form 10-KSB, 11-K,
10-QSB,  N-SAR, or the transition report or portions thereof, could not be filed
with  the  prescribed  time  period.  (Attach  Extra  Sheets  if  Needed)

     The Registrant's Report on Form 10-KSB for the period ended August 31, 2000
could  not  be  filed  within  the  prescribed time period because management is
trying to accumulate the information needed by its accountants in preparation of
the  Registrant's annual report.  Serious doubts have arisen as to the Company's
ability  to  continue  as a going concern.  The Company has continued to sustain
losses which are significant.  The Company does not have funds available at this
time  to  continue  operations  for  any  significant  period of time, without a
significant  capital infusion.  The Company continues to seek additional funding
and merger and affiliation candidates, but to date no funding or transaction has
been secured, nor can any assurance be given that it can or will be accomplished
in  a  time  frame  to  permit the Company's continued operations.  Accordingly,
while  management  of  the Company continues to seek opportunities to permit the
Company  to  continue  operations,  the Company may seek  protection  under  the
bankruptcy  laws  in  the  near  future.


<PAGE>
                           PART IV - OTHER INFORMATION

(1)     Name  and  telephone  number  of  person  to  contact  in regard to this
notification

     CHARLES R. DRUMMOND                (303)                    279-9375
     -------------------                -----               ------------------
          (Name)                    (Area  Code)            (Telephone Number)


(2)     Have  all  other  periodic reports required under Section 13 or 15(d) of
the  Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of  1940  during  the  preceding 12 months (or for such shorter) period that the
registrant  was  required  to  file  such  reports) been filed?  If answer is no
identify  report(s).
YES   X      NO
     ---         ---


(3)     It  is  anticipated that any significant change in results of operations
from  the corresponding period for the last fiscal year will be reflected by the
earnings  statements  to  be  included in the subject report or portion thereof?
YES         NO   X
     ---        ---

If  so,  attach  an  explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of  the  results  cannot  be  made.

   [IF  THE  ANSWER ABOVE IS YES, THEN USE THIS SPACE TO GIVE THE EXPLANATION]

                                DOCPLANET.COM, INC.
                    ---------------------------------------
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to  be  signed on its behalf by the undersigned
hereunto  duly  authorized.

Date:        December 1, 2000                 By:  /s/  CHARLES R. DRUMMOND
             -----------------                   --------------------------
                                                      CHARLES R. DRUMMOND
                                                      CHIEF EXECUTIVE OFFICER


     INSTRUCTION:  The  form  may  be  signed  by  an  executive  officer of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the  registrant  by  an  authorized
representative  (other  than  the  executive  officer),  evidence  of  the
representative's  authority  to  sign on behalf of the registrant shall be filed
with  the  form.


<PAGE>
             ------------------------------------------------------
                                    ATTENTION

            Intentional misstatements or omissions of fact constitute
               Federal Criminal Violations (See 18 U.S.C. 1001).l

             ------------------------------------------------------

1.     This  form is required by Rule 12b-25 (17 CFR 240, 12b-25) of the General
Rules  and  Regulations  under  the  Securities  Exchange  Act  of  1934.

2.     One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange Commission,
Washington,  D.C.  20549,  in  accordance with Rule 0-3 of the General Rules and
Regulations  under  the Act. The information contained in or filed with the form
will  be  made  a  matter  of  public  record  in  the  Commission  files.

3.     A  manually signed copy of the form and amendments thereto shall be filed
with  each  nations  securities exchange on which any class of securities of the
registrant  is  registered.

4.     Amendments  to  the  notifications  must also be filed on form 12b-25 but
need  not restate information that has been correctly furnished.  The form shall
be  clearly  identified  as  an  amended  notification.


<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission